CASI is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.
HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
MyStockHarbor.com
NEWS SCORE
44/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
28
Weak based on actual EPS/revenue
Confidence
Low
Headline depth
Last Price
$0.15
Trend Context
Mixed / range
Latest briefing
What's happening with CASI
Stock Titan15 Jul 2026
CASI Pharmaceuticals (CASIF) granted over RMB 100M in Juventas arbitration - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPM0JhQXFzNFZWSTh3STg0eG1YYUxjdUNhVHpzaEExNlFYbFp4RnNxem5xZFdJRFY0blZ3VTh0akhsVkZ5TDhQM3VqWDZtRU9odmZtNndENlExQUMwbW9hTloyQTN2ZEw3TVhKTE1EMmh5SmN0d3JvVmQ3M1lDYmswRl83TzNuZDVVNzBWN2FINVNlV2FGS01fTGxlZ2JyOWgwVmVvTWc5YlJBSzFYQVJxT0JaTmF5NW5qSnFURVRB?oc=5" target="_blank">CASI Pharmaceuticals (CASIF) granted over RMB 100M in Juventas arbitration</a> <font color="#6f6f6f">Stock Titan</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Stocktwits13 Jul 2026
Why Did CASI Stock Plummet 64% Today To Hit An All-Time Low? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNZHd4YnZSQVNBdW5hT3RkVmZsMGdqdWFOaEJiSXE4Qm1OZmhLNnBPdWk5ODZCY0N5eXFqbjByRy13TFVMckp5Z195NFFuSm1xc29zM1RaMzVzV2p0YjJTcHFOYnR0aTNYM3g3WkdyMF9Jd0x6T0NOU1dfZldycExsLTVsajUyOVlOa3ppcGFxMVpBUmwwanNhV3RLX09YdUI0WGQ5UEdfT0FzSjdrdVRpZXp3cFBmLVk?oc=5" target="_blank">Why Did CASI Stock Plummet 64% Today To Hit An All-Time Low?</a> <font color="#6f6f6f">Stocktwits</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
The Globe and Mail30 Jun 2026
CASI Pharmaceuticals Rescinds Evomela License Termination in Settlement With Acrotech - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxOUUFaYWtPREVLYnBBNGE3aEZmV0p5dWtBVnVsV1lUYmFNR19xeFFuamhBVXV4N3g1TTZOei1qa3VJRFNLbUF4dGJpRTQ4bVJHcFhIZUZLVG1jSXJHOTZPdjF4YkZLTlJuaHJaTElTd3pESzhaamtrWEZZTE82SmkyMHVteWxLaW8tVGRhdVYwbmJ1WEd3WGMwRHByc0tPYWNLcjFwQVhiQnBpUlZpbkYtMnZXdE1jVG9jTXVTTjkycXNHaDJrbzJaTWtYdlRFMm9ZdUY5NExiSFRYSmN5QkJyd2NPLVhHSHN3VUtEVUREaVVCVWw3YmluY19n?oc=5" target="_blank">CASI Pharmaceuticals Rescinds Evomela License Termination in Settlement With Acrotech</a> <font colo…
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
Idéal Investisseur
22 May 2026
MaaT Pharma's Stock Rebounds Nearly 7% After Yesterday's Collapse, Ahead of CHMP Vote - Idéal Investisseur
